Home › Companies › PTC Therapeutics, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and PTC Therapeutics, Inc.’s Form 8-K, filed June 5, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 2, 2026: 4 items on PTC Therapeutics, Inc.’s Form 8-K, filed June 5, 2026: 4 passed (calculated).
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Tang Capital (13F, 1.8%, as of September 30, 2026)
Explore PTC Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are PTC Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jessica Chutter | 71,945,515 | -- | -- | 737,780 | 3,858,311 | 99% | Passed (calculated) | — |
| Elect Director: Matthew B. Klein, M.D., M.S., F.A.C.S. | 71,550,878 | -- | -- | 1,132,417 | 3,858,311 | 98% | Passed (calculated) | — |
| Elect Director: Stephanie S. Okey, M.S. | 68,902,707 | -- | -- | 3,780,588 | 3,858,311 | 95% | Passed (calculated) | — |
| Elect Director: Jerome B. Zeldis, M.D., Ph.D. | 69,821,943 | -- | -- | 2,861,352 | 3,858,311 | 96% | Passed (calculated) | — |
Source: PTC Therapeutics, Inc., Form 8-K, filed with the SEC on June 5, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
349 asset managers disclosed a vote on at least one PTC Therapeutics, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PTC Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Four Class I Directors: Jerome B. Zeldis, M.D., Ph.D.
PTC Therapeutics, Inc.’s own tally for this item (“Elect Director: Jerome B. Zeldis, M.D., Ph.D.”): 69,821,943 for, 2,861,352 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 111 asset managers below reported 36,152,747 for, 630,941 withheld, 268,996 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,913,366 | 0 | 20 | 0 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,643,965 | 0 | 0 | 146 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 324,181 | Withhold |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 66,033 | 0 | 218,556 | 0 | Mixed |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 132,509 | 0 | 0 | 59,080 | Mixed |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Showing the 25 largest of 111 asset managers. All 111 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Four Class I Directors: Jessica Chutter
PTC Therapeutics, Inc.’s own tally for this item (“Elect Director: Jessica Chutter”): 71,945,515 for, 737,780 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 111 asset managers below reported 36,682,283 for, 106,772 withheld, 263,629 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,913,382 | 0 | 4 | 0 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,644,111 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,181 | 0 | 0 | 0 | For |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 66,033 | 0 | 218,556 | 0 | Mixed |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 191,589 | 0 | 0 | 0 | For |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Showing the 25 largest of 111 asset managers. All 111 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Four Class I Directors: Matthew B. Klein, M.D., M.S., F.A.C.S.
PTC Therapeutics, Inc.’s own tally for this item (“Elect Director: Matthew B. Klein, M.D., M.S., F.A.C.S.”): 71,550,878 for, 1,132,417 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 111 asset managers below reported 36,682,135 for, 106,918 withheld, 263,631 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,913,380 | 0 | 6 | 0 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,643,965 | 0 | 0 | 146 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,181 | 0 | 0 | 0 | For |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 66,033 | 0 | 218,556 | 0 | Mixed |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 191,589 | 0 | 0 | 0 | For |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Showing the 25 largest of 111 asset managers. All 111 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Four Class I Directors: Stephanie S. Okey, M.S.
PTC Therapeutics, Inc.’s own tally for this item (“Elect Director: Stephanie S. Okey, M.S.”): 68,902,707 for, 3,780,588 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 111 asset managers below reported 36,059,274 for, 724,415 withheld, 268,996 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,900,994 | 0 | 20 | 12,373 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,644,111 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 324,181 | Withhold |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 66,033 | 0 | 218,556 | 0 | Mixed |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 132,509 | 0 | 0 | 59,080 | Mixed |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Showing the 25 largest of 111 asset managers. All 111 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,913,378 | 8 | 0 | 0 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,644,111 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,181 | 0 | 0 | 0 | For |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 284,589 | 0 | 0 | 0 | For |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 191,589 | 0 | 0 | 0 | For |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Fund voting reports, all 110 managers: 36,973,668 for, 6,728 against, 13,167 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 11,209,345 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 7,746,415 | 0 | 0 | 0 | For |
| State Street | 4,110,340 | 0 | 0 | 0 | For |
| Wellington | 3,445,221 | 0 | 0 | 0 | For |
| BlackRock | 2,896,661 | 1,118 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,217,194 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 1,593,575 | 0 | 0 | 0 | For |
| Fidelity | 1,473,769 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,099,372 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,080,589 | 0 | 0 | 0 | For |
| DE Shaw | 958,390 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 918,846 | 0 | 0 | 0 | For |
| Charles Schwab | 735,665 | 0 | 0 | 0 | For |
| Invesco | 718,347 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 711,457 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 681,917 | 0 | 0 | 0 | For |
| Vanguard | 678,275 | 0 | 0 | 0 | For |
| Nuveen | 650,233 | 0 | 0 | 0 | For |
| Northern Trust | 640,082 | 0 | 0 | 0 | For |
| Boston Partners | 633,462 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 606,999 | 0 | 0 | 0 | For |
| T. Rowe Price | 577,324 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 517,057 | 0 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 516,933 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 512,828 | 0 | 0 | 0 | For |
Institutional-manager reports, all 269 managers: 53,834,093 for, 991,430 against, 34 abstained, 343 not voted. Showing the 25 largest; every one is in the interactive database (link above).
99.9% of fund votes cast · no official result
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
The 110 asset managers below reported 36,931,534 for, 33,510 against, 13,167 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,913,384 | 2 | 0 | 0 | For |
| BlackRock | 8,919,225 | 0 | 0 | 0 | For |
| Fidelity | 3,183,248 | 0 | 0 | 0 | For |
| State Street | 2,643,965 | 146 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,908,579 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 988,439 | 0 | 0 | 0 | For |
| Charles Schwab | 677,090 | 0 | 0 | 0 | For |
| Invesco | 663,622 | 0 | 0 | 0 | For |
| TIAA | 628,538 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 488,115 | 0 | 0 | 0 | For |
| Lord Abbett | 385,360 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 337,477 | 0 | 0 | 0 | For |
| T. Rowe Price | 324,181 | 0 | 0 | 0 | For |
| Jackson National | 299,094 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 284,589 | 0 | 0 | 0 | For |
| Hartford | 262,612 | 0 | 0 | 0 | For |
| Dimensional | 225,758 | 0 | 0 | 0 | For |
| Voya | 220,168 | 0 | 0 | 0 | For |
| Equitable | 191,589 | 0 | 0 | 0 | For |
| Loomis Sayles | 176,905 | 0 | 0 | 0 | For |
| Federated Hermes | 148,171 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 147,623 | 0 | 0 | 0 | For |
| Russell Investments | 138,672 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 137,087 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,843 | 0 | 0 | 0 | For |
Showing the 25 largest of 110 asset managers. All 110 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 82,882,024 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 13.17% |
| 2 | BlackRock | 10.76% |
| 3 | Fidelity | 3.84% |
| 4 | State Street | 3.19% |
| 5 | JANUS INVESTMENT FUND | 2.30% |
| 6 | Manager Directed Portfolios | 1.19% |
| 7 | Charles Schwab | 0.82% |
| 8 | Invesco | 0.80% |
| 9 | TIAA | 0.76% |
| 10 | FRANKLIN STRATEGIC SERIES | 0.59% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 13.52% |
| 2 | RTW INVESTMENTS, LP | 9.35% |
| 3 | State Street | 4.96% |
| 4 | Wellington | 4.16% |
| 5 | BlackRock | 3.50% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.68% |
| 7 | Hood River Capital Management LLC | 1.92% |
| 8 | Fidelity | 1.78% |
| 9 | FRANKLIN ADVISERS INC | 1.33% |
| 10 | PICTET ASSET MANAGEMENT SA | 1.30% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 12,948,717 | 15.62% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 8,803,203 | 10.62% | Form 13F, quarter ended March 31, 2026 |
| RTW Investments L.P. | 7,423,970 | 8.96% | Proxy statement (DEF 14A), table as of April 10, 2026 |
| JANUS HENDERSON GROUP PLC | 7,193,433 | 8.68% | Schedule 13G, filed May 15, 2026 |
| Vanguard Portfolio Management | 4,871,329 | 5.88% | Schedule 13G, filed April 29, 2026 |
| STATE STREET CORPORATION | 4,206,126 | 5.07% | Schedule 13G, filed February 9, 2026 |
| Wellington Management | 3,942,610 | 4.76% | Form 13F, quarter ended March 31, 2026 |
| The Toronto-Dominion Bank | 3,025,945 | 3.65% | Schedule 13G, filed May 15, 2026 |
| Michael Schmertzler | 1,749,689 | 2.11% | Proxy statement (DEF 14A), table as of April 10, 2026 |
| D.E. Shaw | 1,640,381 | 1.98% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 82,882,024 shares outstanding, as reported by PTC Therapeutics, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At PTC Therapeutics, Inc.'s shareholder meeting held June 2, 2026, in the 2025-2026 proxy season, 349 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 3,025 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. PTC Therapeutics, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval on a non-binding, advisory basis, of the Company's named executive officer… — the reporting funds and managers cast 99% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PTC Therapeutics, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
PTC Therapeutics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “PTC Therapeutics (PTCT) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/ptc-therapeutics-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.